MIMS masterclass focuses on neuropathic bladder

Expert presentations and opportunities to discuss individual cases with colleagues are on offer at the MIMS Neuropathic Bladder Masterclass taking place on 30th June in Middlesbrough.

The free-to-attend masterclass features presentations on what's new in management of the neuropathic bladder, clinical experience of drug therapy for neurogenic detrusor overactivity, and quality of life for spine-injured patients with bladder problems.

Presentations will be followed by an interactive discussion of key cases among colleagues from different disciplines.

Learning outcomes for the day will be better awareness of effective drug and other therapy for bladder problems, and an improved ability to advise patients on treatment options and optimising quality of life.

CPD credits

The masterclass has been awarded 2 CPD credits by the British Association of Urological Surgeons and registration is open to any healthcare professional with an interest in neuropathic bladder problems, from a medical, nursing or other healthcare discipline.

The half-day masterclass starts with a buffet lunch at 13.00pm and closes at 16.40pm. The venue is James Cook University Hospital, Middlesbrough.

The event is initiated and funded by AMCo Amdipharm Mercury. Full details of the programme and details of how to register can be found at http://www.mims.co.uk/events/masterclass-middlesbrough

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

'Innovative' heart failure treatment recommended by NICE

'Innovative' heart failure treatment recommended by NICE

Dapagliflozin (Forxiga), the first SGLT2 inhibitor...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Pregabalin linked to severe respiratory depression in absence of opioids

Pregabalin linked to severe respiratory depression in absence of opioids

The MHRA advises prescribers to consider adjustment...